TY - JOUR AU - Sehgal, Kartik AU - Patell, Rushad AU - Rangachari, Deepa AU - Costa, Daniel B. PY - 2018 TI - Targeting ROS1 rearrangements in non-small cell lung cancer with crizotinib and other kinase inhibitors JF - Translational Cancer Research; Vol 7, Supplement 7 (August 28, 2018): Translational Cancer Research Y2 - 2018 KW - N2 - The discovery of molecular subtypes of non-small cell lung cancer (NSCLC) with oncogenic driver mutations and translocations/rearrangements has led to successful development of targeted therapies and improvement in outcomes of advanced lung cancer patients. UR - https://tcr.amegroups.org/article/view/23480